Drug Profile
Research programme: human butyrylcholinesterase - TNO
Alternative Names: HuBuChE - TNOLatest Information Update: 07 Oct 2014
Price :
$50
*
At a glance
- Originator TNO
- Developer BBB Therapeutics; TNO
- Class Antidotes; Butyrates; Cholinesterases
- Mechanism of Action Scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Poisoning
Most Recent Events
- 07 Oct 2014 No development reported for Poisoning in Netherlands (unspecified route)
- 30 Sep 2014 to-BBB technologies is now called BBB Therapeutics